Home › Peripheral Arterial Disease › Nebraska
Peripheral Arterial Disease clinical trials in Nebraska
8 studies for Peripheral Arterial Disease are looking for participants at sites in Nebraska.
Cities in Nebraska
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- GSR Enterprises, Inc., Lincoln
- Great Plains Health - Nephrology, North Platte
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Detecting Peripheral Artery Disease With the Pulse
- University of Nebraska at Omaha Health Science Collaborative, Omaha
RecruitingHealthy volunteers welcome
Ages 19 and older · All sexes · Updated Sep 17, 2026 · NCT07226193Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
- University of Nebraska - Omaha, Omaha
RecruitingEarly phase 1Healthy volunteers welcome
Ages 50 to 75 · All sexes · Updated Jun 24, 2026 · NCT06319339MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
- VA Medical Center, Omaha
Recruiting
Ages 21 and older · All sexes · Updated Feb 24, 2026 · NCT06409949Oxygen-guided Supervised Exercise Therapy
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Recruiting
All ages · All sexes · Updated Jan 13, 2026 · NCT06003855Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 19 to 89 · All sexes · Updated Oct 22, 2025 · NCT06480786Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
- VA Medical Center, Omaha
RecruitingPhase 4
Ages 18 to 90 · All sexes · Updated May 23, 2025 · NCT02842424From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.